M PREMKUMAR

833 posts

M PREMKUMAR

M PREMKUMAR

@docMPK

Stranger in a Strange Land

Chandigarh, India Katılım Mayıs 2021
368 Takip Edilen1.1K Takipçiler
M PREMKUMAR
M PREMKUMAR@docMPK·
@IvaKosuta Thanks Iva!! Hope to see you work with us on the next one.🗺 prospective data needed.
English
0
0
1
6
Iva Košuta
Iva Košuta@IvaKosuta·
New study challenges albumin use in cirrhosis + septic shock. POCUS-guided resuscitation showed NO mortality difference between 20% albumin+BSS vs BSS alone at 28d (36.5% vs 31.8%) or 90d. The key predictor? Cirrhotic cardiomyopathy (CCM), not fluid choice. 🫀💉
M PREMKUMAR@docMPK

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… For liver POCUS aficionados. @JCEH_Hepatology @hepocus @RoyAHep @manhalizzy @KavishPatidar11 @RohitMehtaniDM @AnandVKulkarni2 @KoraAbhi @IvaKosuta @DivyaveerSSNeph @pummy92 @MaiwallRakhi @stevenbollipo @giri_gutnliver @drkeithsiau @SakkarinC @Apichatka

English
2
2
8
901
Suprabhat Giri
Suprabhat Giri@giri_gutnliver·
All that Gastro & Liver...Happy to share the publication of 11 manuscripts (7 original articles, 2 systematic review/meta-analysis, 2 review) in the month of February with 9 from @KIMSGastro & 2 from KEM... Extremely thankful to all my seniors and colleagues for their support...
Suprabhat Giri tweet media
English
7
0
48
1.8K
M PREMKUMAR retweetledi
Hepatoma Research
Hepatoma Research@HepatomaRes·
💬 In cirrhotic patients with #HCC, how do you approach thrombotic risk assessment? 🔘 Routine screening 🔘 Case-by-case 🔘 Mainly after PVT occurs 🔘 No standardized approach #LiverCancer #Hepatology @manhalizzy @rav7ks @MichaelAlbertMD @docMPK @perillo_prazole @katiewiskar
Hepatoma Research@HepatomaRes

🩸 This review highlights the burden of local and systemic thrombosis in #cirrhotic patients with #hepatocellular carcinoma, with a focus on portal vein thrombosis and its impact on treatment eligibility and outcomes. 🔗 [f.oaes.cc/xmlpdf/e476641…]

English
0
1
5
352
M PREMKUMAR
M PREMKUMAR@docMPK·
🧵2 Restrictive and Effective POCUS guided volume resuscitation works best. Shock is a spectrum...Phenotypes are between Fluid responsive to circulatory failure. ✅️⏳️Time based perfusion targets reduce mortality. Assessment of CCM and Fluid challenge ➡️ 'cardiac reserve'
M PREMKUMAR tweet media
English
0
0
5
201
Akash Roy
Akash Roy@RoyAHep·
BLS 2026 concludes and it leaves behind memories, learnings,smiles A mid-term @INASL_Liver saw a family coming together with 600 registrations, 140 faculty, 13 international experts & 100+📝 The People, the Conversations and Camaraderie made this journey special 🙏🏽🙏🏽Everyone
Akash Roy tweet mediaAkash Roy tweet mediaAkash Roy tweet mediaAkash Roy tweet media
English
4
8
29
1.9K